Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 22;17(6):373.
doi: 10.3390/md17060373.

Metabolites of Seaweeds as Potential Agents for the Prevention and Therapy of Influenza Infection

Affiliations
Review

Metabolites of Seaweeds as Potential Agents for the Prevention and Therapy of Influenza Infection

Natalia Besednova et al. Mar Drugs. .

Abstract

Context: Seaweed metabolites (fucoidans, carrageenans, ulvans, lectins, and polyphenols) are biologically active compounds that target proteins or genes of the influenza virus and host components that are necessary for replication and reproduction of the virus.

Objective: This review gathers the information available in the literature regarding to the useful properties of seaweeds metabolites as potential agents for the prevention and therapy of influenza infection.

Materials and methods: The sources of scientific literature were found in various electronic databases (i.e., PubMed, Web of Science, and ScienceDirect) and library search. The retrospective search depth is 25 years.

Results: Influenza is a serious medical and social problem for humanity. Recently developed drugs are quite effective against currently circulating influenza virus strains, but their use can lead to the selection of resistant viral strains. In this regard, new therapeutic approaches and drugs with a broad spectrum of activity are needed. Metabolites of seaweeds fulfill these requirements. This review presents the results of in vitro and in vivo experimental and clinical studies about the effectiveness of these compounds in combating influenza infection and explains the necessity of their use as a potential basis for the creation of new drugs with a broad spectrum of activity.

Keywords: Flu; alga; alginates; anti-viral activity; lectins; polyphenols; sulphated polysaccharides.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this article.

Figures

Figure 1
Figure 1
The life cycle of influenza virus.
Figure 2
Figure 2
Antiviral activity of algae metabolites.

Similar articles

Cited by

References

    1. Lvov N.I., Likhopoenko V.P. Acute respiratory infections. Guide to infectious diseases. StP: Foliant. 2011;2:7–122.
    1. Osidak L.V., Drinevskiy V.P., Erofeeva M.K., Eropkin M.Y., Konovalov N.I., Smororintsev E.A., Golovacheva E.G., Donluray E.A., Baybus A.M., Wojciechowska E.M., et al. Influenza A (H1N1) 2009 in Russia. Terra Medica Nova. Infect. Dis. 2009;4–5:6–9. (In Rissian)
    1. Henrickson K.J., Hoover S., Kehl K.S., Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr. Infect. Dis. J. 2004;23(Suppl. 1):S11–S18. doi: 10.1097/01.inf.0000108188.37237.48. - DOI - PubMed
    1. Vasin A.V., Sologub T.V., Tsybalova L.M., Tokin I.I., Tsvetkov V.V. Influenza in the practice of a clinician, an epidemiologist and a virologist. Med. Inf. Agency Moscow. 2017:272. (In Russian)
    1. Sologub T.V. Influenza in modern conditions. Med. Council. 2015;4:36–45. (In Russian)

MeSH terms